- Home
- BBCP vs ABEO Comparison
BBCP vs ABEO Comparison
Compare BBCP & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBCP | ABEO |
|---|---|---|
| Founded | 1983 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 333.0M | 280.2M |
| IPO Year | 2017 | 1980 |
Fundamental Metrics
Financial Performance| Metric | BBCP | ABEO |
|---|---|---|
| Price | $6.43 | $5.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $7.50 | ★ $18.20 |
| AVG Volume (30 Days) | 139.3K | ★ 1.2M |
| Earning Date | 03-10-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.09 | ★ 1.29 |
| Revenue | ★ $392,867,000.00 | $400,000.00 |
| Revenue This Year | $3.49 | N/A |
| Revenue Next Year | $4.54 | $1,589.77 |
| P/E Ratio | $72.64 | ★ $3.99 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.78 | $3.93 |
| 52 Week High | $8.05 | $7.54 |
Technical Indicators
Market Signals| Indicator | BBCP | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 48.85 | 46.34 |
| Support Level | $5.89 | $4.90 |
| Resistance Level | $6.32 | $5.42 |
| Average True Range (ATR) | 0.25 | 0.23 |
| MACD | 0.04 | -0.03 |
| Stochastic Oscillator | 94.77 | 35.43 |
Price Performance
Historical ComparisonAbout BBCP Concrete Pumping Holdings Inc.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.